VANCOMYCIN THERAPY OF OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS

被引:38
|
作者
KLASTERSKY, J [1 ]
COPPENS, L [1 ]
VANDERAUWERA, P [1 ]
MEUNIERCARPENTIER, F [1 ]
机构
[1] UNIV LIBRE BRUXELLES,INST JULES BORDET,CTR TUMEURS,LAB INVEST CLIN HJ TAGNON,B-1000 BRUSSELS,BELGIUM
关键词
D O I
10.1093/jac/11.4.361
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:361 / 367
页数:7
相关论文
共 50 条
  • [21] Phylogenetic analysis of livestock oxacillin-resistant Staphylococcus aureus
    Hsieh, Jui-Ming
    Chen, Ren-Shinn
    Tsai, Tsung-Yu
    Pan, Tzu-Ming
    Chou, Chin-Cheng
    [J]. VETERINARY MICROBIOLOGY, 2008, 126 (1-3) : 234 - 242
  • [22] INVITRO ACTIVITY OF NOVOBIOCIN AND RIFAMPIN ALONE AND IN COMBINATION AGAINST OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    JOHNSTON, BL
    KWOK, RYY
    MULLIGAN, ME
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 8 (03) : 137 - 147
  • [23] A class A β-lactamase produced by borderline oxacillin-resistant Staphylococcus aureus hydrolyses oxacillin
    Nomura, Ryo
    Nakaminami, Hidemasa
    Takasao, Kotaro
    Muramatsu, Shuna
    Kato, Yuji
    Wajima, Takeaki
    Noguchi, Norihisa
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2020, 22 : 244 - 247
  • [24] VANCOMYCIN THERAPY FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    SORRELL, TC
    PACKHAM, DR
    SHANKER, S
    FOLDES, M
    MUNRO, R
    [J]. ANNALS OF INTERNAL MEDICINE, 1982, 97 (03) : 344 - 350
  • [25] Oxacillin-resistant and multidrug-resistant staphylococcus aureus in Lima, Peru
    Seas, C.
    Hernandez, K.
    Ramos, R.
    Bazan, E.
    Rodriguez, I.
    Torres, A.
    Zamudio, C.
    Gotuzzo, E.
    [J]. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (02): : 198 - 200
  • [26] EPIDEMIOLOGIC MARKERS FOR EPIDEMIC STRAIN AND CARRIER ISOLATES IN AN OUTBREAK OF NOSOCOMIAL OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    BOUVET, A
    FOURNIER, JM
    AUDURIER, A
    BRANGER, C
    ORSONI, A
    GIRARD, C
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (06) : 1338 - 1341
  • [27] PHENOTYPICAL AND GENOTYPIC CHARACTERIZATION OF EPIDEMIC CLUMPING FACTOR-NEGATIVE, OXACILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS
    SCHWARZKOPF, A
    KARCH, H
    SCHMIDT, H
    LENZ, W
    HEESEMANN, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1993, 31 (09) : 2281 - 2285
  • [28] OXACILLIN-RESISTANT STAPHYLOCOCCUS AUREUS: AN EMERGING PATHOGEN IN OUR SERVICE?
    Aiello, Talita Bianchi
    Arrym, Mauro Pedromonico
    Mauch, Renan Marrichi
    Ribeiro, Jose Dirceu
    Ribeiro, Antonio Fernando
    Levy, Carlos Emilio
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : S32 - S32
  • [29] Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus
    Climo, MW
    Ehlert, K
    Archer, GL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) : 1431 - 1437
  • [30] Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides
    Rello, J
    Sole-Violan, J
    Sa-Borges, M
    Garnacho-Montero, J
    Muñoz, E
    Sirgo, G
    Olona, M
    Diaz, E
    [J]. CRITICAL CARE MEDICINE, 2005, 33 (09) : 1983 - 1987